Literature DB >> 10097005

Sympathetic nervous system and pain: a clinical reappraisal.

H Blumberg1, U Hoffmann, M Mohadjer, R Scheremet.   

Abstract

The target article discusses various aspects of the relationship between the sympathetic system and pain. To this end, the patients under study are divided into three groups. In the first group, called "reflex sympathetic dystrophy" (RSD), the syndrome can be characterized by a triad of autonomic, motor, and sensory symptoms, which occur in a distally generalized distribution. The pain is typically felt deeply and diffusely, has an orthostatic component, and is suppressed by the ischemia test. Under those circumstances, the pain is likely to respond to sympatholytic interventions. In a second group, called "sympathetically maintained pain" (SMP) syndrome, the principal symptoms are spontaneous pain, which is felt superficially and has no orthostatic component, and allodynia. These symptoms, typically confined to the zone of a lesioned nerve, may also be relieved by sympathetic blocks. Since the characteristics of the pain differ between RSD and SMP, the underlying kind of sympathetic-sensory coupling may also vary between these cases. A very small third group of patients exhibits symptoms of both RSD and SMP. The dependence or independence of pain on sympathetic function reported in most published studies seems to be questionable because the degree of technical success of the block remains uncertain. Therefore, pain should not be reported as sympathetic function independent until the criteria for a complete sympathetic block have been established and satisfied.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10097005     DOI: 10.1017/s0140525x97271487

Source DB:  PubMed          Journal:  Behav Brain Sci        ISSN: 0140-525X            Impact factor:   12.579


  6 in total

Review 1.  Controversies surrounding reflex sympathetic dystrophy: a review article.

Authors:  R P Pawl
Journal:  Curr Rev Pain       Date:  2000

2.  The Tourniquet Ischemia Test Effectively Predicts the Efficacy of Lumbar Sympathetic Block in Patients with Lower Extremity Complex Regional Pain Syndrome Type 1.

Authors:  Yongming Xu; Qingqing Jiang; Xiaoliang Xu; Junzhen Wu; Dongping Du; Shaofeng Pu; Yingying Lv; Chen Li
Journal:  J Pain Res       Date:  2022-06-07       Impact factor: 2.832

3.  Lumbar sympathetic blockade in children with complex regional pain syndromes: a double blind placebo-controlled crossover trial.

Authors:  Petra M Meier; David Zurakowski; Charles B Berde; Navil F Sethna
Journal:  Anesthesiology       Date:  2009-08       Impact factor: 7.892

4.  Buprederm, a new transdermal delivery system of buprenorphine: pharmacokinetic, efficacy and skin irritancy studies.

Authors:  In Park; Dongwon Kim; Jindeog Song; Chang Hoon In; Seung-Wei Jeong; Sang Hun Lee; Bumchan Min; Dongho Lee; Sun-Ok Kim
Journal:  Pharm Res       Date:  2008-02-01       Impact factor: 4.200

5.  Norepinephrine-evoked pain in fibromyalgia. A randomized pilot study [ISRCTN70707830].

Authors:  Manuel Martinez-Lavin; Marcela Vidal; Rosa-Elda Barbosa; Carlos Pineda; Jose-Miguel Casanova; Arnulfo Nava
Journal:  BMC Musculoskelet Disord       Date:  2002-01-16       Impact factor: 2.362

6.  Interaction of hyperalgesia and sensory loss in complex regional pain syndrome type I (CRPS I).

Authors:  Volker Huge; Meike Lauchart; Stefanie Förderreuther; Wibke Kaufhold; Michael Valet; Shahnaz Christina Azad; Antje Beyer; Walter Magerl
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.